Pathogenesis of rheumatoid arthritis: one year in review 2023.

Autor: Mariani FM; Department of Life, Health and Environmental Sciences, University of L'Aquila; Internal Medicine and Nephrology Division, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy., Martelli I; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Pistone F; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Chericoni E; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Puxeddu I; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Alunno A; Department of Life, Health and Environmental Sciences, University of L'Aquila; Internal Medicine and Nephrology Division, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy. alessia.alunno82@gmail.com.
Jazyk: angličtina
Zdroj: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2023 Sep; Vol. 41 (9), pp. 1725-1734. Date of Electronic Publication: 2023 Jul 24.
DOI: 10.55563/clinexprheumatol/sgjk6e
Abstrakt: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by local and systemic inflammation. The complex interplay between immune cells and soluble mediators leads to the induction and perpetuation of aberrant inflammatory and autoimmune responses. The research carried out in the last year in the field of RA enabled the identification of new mechanisms involved in the pathogenesis of the disease and therefore unmasked new potential therapeutic targets. In this review article we summarised the new insights into RA pathogenesis from original research articles published in the last year.
Databáze: MEDLINE